REM sleep behaviour disorder (RBD) is an often debilitating condition that causes people to act out in their sleep, sometimes violently. What鈥檚 worse, people with the disorder often go on to develop Parkinson鈥檚 disease.
听
Gene therapy for rare neurological disorders will move one step forward thanks to a $1.14 million grant from the Canadian Institutes of Health Research (CIHR).
An innovative new program based at The Neuro has received $2.6 million from the CQDM and the Brain Canada Foundation.
Neuroplasticity is the brain鈥檚 ability to build connections within itself, adapting to the surrounding environment. The brain is most plastic in childhood, forming new pathways in reaction to stimuli such as language.
Alan Evans, a researcher at The Neuro, James 缅北强奸 Professor of Neurology and Neurosurgery and co-director of the Ludmer Centre for Neuroinformatics and Mental Health, has been elected to the Fellowship of the Royal Society, joining a class of scientists that includes a Nobel laureate and a former Chief Medical Advisor to the US President.听听
The Paris Brain Institute and the Institut Pasteur have partnered with The Neuro to fund two groundbreaking studies, each receiving more than $440,000. These projects are part of an international collaboration to address future challenges in neuroscience.
听
A new project at The Neuro, 缅北强奸 and the Research Institute of the 缅北强奸 Health Centre (RI-MUHC) has been awarded $10.6M in financial support as part of the Canada Foundation for Innovation鈥檚 (CFI) Innovation Fund.
听
One of the things that makes developing effective treatments for Parkinson鈥檚 disease so challenging is its complexity. While some forms are caused by genetics, others have environmental factors, and patients can show a wide range of symptoms of varying severity. Diagnosis of Parkinson鈥檚 is also currently made very late, after the disease may have been in the brain for a decade or more.
Virtual reality simulators can help learners improve their technical skills faster and with no risk to patients. In the field of neurosurgery, they allow medical students to practice complex operations before using a scalpel on a real patient. When combined with artificial intelligence, these tutoring systems can offer tailored feedback like a human instructor, identifying areas where the students need to improve and making suggestions on how to achieve expert performance.
A study of more than 22,000 people with multiple sclerosis has discovered the first genetic variant associated with faster disease progression, which can rob patients of their mobility and independence over time.
听
Patients can now digitally consent to be included in The Neuro鈥檚 Open Biobank (Clinical Biospecimen Imaging and Genetic Repository) and patient registry, providing a more efficient and easier way to help patients accelerate neurological disorder research and participate in clinical trials. The new platform is financially supported by Novartis Pharmaceuticals Canada Inc.
A $6M grant from Brain Canada will fund the creation of a new Open Science patient registry, to share data with researchers around the world and let patients see how their data is used to develop new treatments for neurological disorders.
Alpha Tau Medical Ltd. the developer of the innovative alpha-radiation cancer therapy Alpha DaRT鈩�, announced today that its first patient with advanced inoperable pancreatic cancer has been treated in a feasibility and safety study of Alpha DaRT at the Jewish General Hospital (JGH) in Montreal, Canada, which is an affiliated teaching hospital of 缅北强奸, Faculty of Medicine.
Two seminal studies from 缅北强奸, investigating immune landscapes of lung and brain tumours, were published today in Nature. This work was led by Logan Walsh, Daniela Quail and Peter Siegel, researchers at the Rosalind and Morris Goodman Cancer Institute and Philippe Joubert from Universit茅 Laval. The studies used innovative highly multiplexed imaging to create sophisticated immune atlases of lung and brain tumours and demonstrate how big data and artificial intelligence are the future of cancer research and clinical care.
